Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Scott

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Biochemistry|May 12, 1981
Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogenM Schapira, C F Scott, R W Colman
Blood|March 1, 1986
Role of arginine residues in the coagulant activity of high molecular weight kininogenJ J Chang, C F Scott, R W Colman
Thrombosis Research|December 15, 1987
A new assay for high molecular weight kininogen in human plasma using a chromogenic substrateC F Scott, R A Pixley, R W Colman
European Journal of Biochemistry|October 1, 1979
Human plasma prekallikrein: a rapid high-yield method for purificationC F Scott, C Y Liu, R W Colman
Archives of Biochemistry and Biophysics|June 1, 1971
Multiple forms of fumarase of pig heartY C Lin, C F Scott, L H Cohen
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1983
Regulation of the hapten-specific T cell response. I. Preferential induction of hyporesponsiveness to the D-end of the major histocompatibility complex in the hapten-specific cytotoxic T cell responseC F Scott, M Tsurufuji, B Benacerraf, et al.
Transfusion|October 1, 1996
More on kininogen measurements in platelet concentrates that are white cell (WBC) reduced with WBC-reduction filtersR W Colman, C F Scott, H Brandwein, et al.
Blood|July 10, 1998
Lack of clinically significant contact system activation during platelet concentrate filtration by leukocyte removal filtersC F Scott, H Brandwein, J Whitbread, et al.
Thrombosis and Haemostasis|January 1, 1997
Rapid direct determination of low and high molecular weight kininogen in human plasma by Particle Concentration Fluorescence Immunoassay (PCFIA)C F Scott, B Shull, W Müller-Esterl, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
Activation of human polymorphonuclear leukocytes by purified human plasma kallikreinM Schapira, C F Scott, L A Boxer, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Biochemistry|May 12, 1981
Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogenM Schapira, C F Scott, R W Colman
Blood|March 1, 1986
Role of arginine residues in the coagulant activity of high molecular weight kininogenJ J Chang, C F Scott, R W Colman
Thrombosis Research|December 15, 1987
A new assay for high molecular weight kininogen in human plasma using a chromogenic substrateC F Scott, R A Pixley, R W Colman
European Journal of Biochemistry|October 1, 1979
Human plasma prekallikrein: a rapid high-yield method for purificationC F Scott, C Y Liu, R W Colman
Archives of Biochemistry and Biophysics|June 1, 1971
Multiple forms of fumarase of pig heartY C Lin, C F Scott, L H Cohen
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1983
Regulation of the hapten-specific T cell response. I. Preferential induction of hyporesponsiveness to the D-end of the major histocompatibility complex in the hapten-specific cytotoxic T cell responseC F Scott, M Tsurufuji, B Benacerraf, et al.
Transfusion|October 1, 1996
More on kininogen measurements in platelet concentrates that are white cell (WBC) reduced with WBC-reduction filtersR W Colman, C F Scott, H Brandwein, et al.
Blood|July 10, 1998
Lack of clinically significant contact system activation during platelet concentrate filtration by leukocyte removal filtersC F Scott, H Brandwein, J Whitbread, et al.
Thrombosis and Haemostasis|January 1, 1997
Rapid direct determination of low and high molecular weight kininogen in human plasma by Particle Concentration Fluorescence Immunoassay (PCFIA)C F Scott, B Shull, W Müller-Esterl, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
Activation of human polymorphonuclear leukocytes by purified human plasma kallikreinM Schapira, C F Scott, L A Boxer, et al.
Pageof 8